Radiation Oncologist Chooses ProCure for Proton Therapy in Personal…

Event summary

Radiation oncologist Edward Soffen, M.D., chose ProCure Proton Therapy Center for his own prostate cancer treatment in 2026.
Dr. Soffen evaluated six treatment options and selected proton therapy for its precision in targeting tumors while sparing healthy tissue.
ProCure has treated over 8,000 patients, including 750+ pediatric cases, since opening in 2012.
Dr. Soffen highlighted ProCure's personalized approach and expertise as key factors in his decision.

The big picture

ProCure's highlight of Dr. Soffen's personal treatment choice underscores the growing importance of personalized medicine in oncology. The case study serves as a strategic asset in differentiating ProCure from competitors, particularly in the context of National Prostate Cancer Awareness Month. The emphasis on proton therapy's precision aligns with broader industry trends toward minimally invasive, targeted treatments that reduce side effects and improve patient outcomes.

What we're watching

Patient Trust: How ProCure's ability to earn patient trust will impact its market position.
Treatment Preferences: Whether the emphasis on proton therapy will drive more referrals and patient volume.
Competitive Differentiation: The pace at which ProCure can sustain its competitive edge through personalized care.